Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina > Presence of multiple eye diseases increases risk of falls/fractures in andividuals
  • Glaucoma

Presence of multiple eye diseases increases risk of falls/fractures in andividuals

Rob Oconnell

People with 1 or more eye diseases, such as cataract, age-related macular degeneration (AMD) and glaucoma, are at increased risk of both falls and fractures, according to findings from a recent study. Improved advice, access, and referrals to falls prevention services may help patients, concluded the study researchers.

Age-related visual loss is thought to be associated with falls and fracture risk, although the evidence is unclear. This cohort population-based study in England used electronic health records with linked hospitalization and mortality records from 2007 to 2020 to evaluate whether people with cataract, AMD, or glaucoma have higher risks of falls or fractures than those without. Participants included people with cataract, AMD, or glaucoma matched to comparators by age, sex, and general practice. Data were analyzed from May 2021 to June 2023. For each eye disease, the researchers estimated the risk of falls or fractures using separate multivariable Cox proportional hazards regression models. The primary outcomes were incident falls and incident fractures derived from general practice, hospital, and mortality records, while secondary outcomes were incident fractures of specific body sites.

A total of 410,476 people with cataract, 75,622 with AMD, and 90,177 with glaucoma were matched to 2,034,194 (no cataract), 375,548 (no AMD), and 448,179 (no glaucoma) comparators. The mean (SD) age was 73.8 years, 79.4 years, and 69.8 years for participants with cataract, AMD, or glaucoma, respectively. Compared with comparators, there was an increased risk of falls in those with cataract (adjusted hazard ratio [HR], 1.36), AMD (HR, 1.25), and glaucoma (HR, 1.38). For fractures, there were increased risks in all eye diseases, with an HR of 1.28 in the cataract cohort, an HR of 1.18 for AMD, and an HR of 1.31 for glaucoma. Site-specific fracture analyses revealed increases in numerous body sites (hip, spine, forearm, skull or facial bones, pelvis, ribs or sternum, and lower leg fractures) compared with matched comparators.

Reference:
Tsang JY, Wright A, Carr MJ, et al. Risk of falls and fractures in individuals with cataract, age-related macular degeneration, or glaucoma. JAMA Ophthalmol. Published online Dec 28, 2023. doi:10.1001/jamaophthalmol.2023.5858

Share

Related Content

  • Glaucoma

Poor sleep quality linked to glaucoma severity in older adults

  • Glaucoma

Glaucoma drainage devices provide meaningful IOP control in pediatric glaucoma

  • Glaucoma

Expanding the glaucoma treatment landscape with FLIGHT technology

  • Retina

Aflibercept 8 mg shows comparable IOP safety to 2 mg through 96 weeks

  • Glaucoma

Geographic differences in glaucoma care raise concerns about equitable access

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon